BISOPROLOL ZENTIVA LAB 2.5 mg, scored tablet 30 tablets
Active ingredients: Bisoprolol monofumarate
Commercialized according to BDPMDispensing in France: Prescription only
Scored tablet30 tabletsorale
No current ANSM shortage notice is included
Package details
Original BDPM fields are shown in French.
- Official name
- BISOPROLOL ZENTIVA LAB 2,5 mg, comprimé sécable
- Pharmaceutical form
- comprimé sécable
- Route of administration
- orale
- Presentation description
- plaquette(s) PVC PVDC aluminium de 30 comprimé(s)
- Marketing authorisation holder
- ZENTIVA FRANCE
- Reimbursement according to BDPM
- 65%
- Approval for use in healthcare institutions
- non
- Commercialization declaration date
- 31 Oct 2023
- Prescription and dispensing conditions
- Prescription only
- List I: prescription-only medicine
- Requires special monitoring during treatment
- Initial prescription by a specialist
- Prescribed by specialists only
- Enhanced ANSM monitoring
- No
BDPM identifiers
CIS
68749248CIP72225803CIP133400922258034Composition in BDPM
| Component | Amount per unit | Source type |
|---|---|---|
| FUMARATE DE BISOPROLOLcomprimé | 2,5 mg · un comprimé | SA |
Information is based on BDPM data and is for reference only. Consult a doctor before use.
Similar medicines
Similar medicines are listed using the official BDPM catalog. Availability must be checked separately. Consult a doctor or pharmacist before switching medicines.